T2 BIOSYSTEMS INC (TTOO) Stock Price, Quote, News and Overview
NASDAQ:TTOO - Nasdaq - US89853L3024 - Common Stock - Currency: USD
TTOO Quote, Performance and Key Statistics
0.134
-0.06 (-31.07%)
The current stock price of TTOO is 0.134 USD. In the past month the price decreased by -58.13%. In the past year, price decreased by -97.54%.
TTOO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.7 | 321.60B | ||
| AMGN | AMGEN INC | 13.07 | 145.89B | ||
| GILD | GILEAD SCIENCES INC | 13.92 | 134.11B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 111.91B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.65 | 65.28B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 38.06B | ||
| ARGX | ARGENX SE - ADR | 99.65 | 35.72B | ||
| ONC | BEIGENE LTD-ADR | 5.89 | 25.49B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.82B | ||
| NTRA | NATERA INC | N/A | 20.54B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.87B | ||
| BIIB | BIOGEN INC | 8.02 | 18.58B |
Related stock screener links
About TTOO
Company Profile
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. The company is headquartered in Lexington, Massachusetts and currently employs 113 full-time employees. The company went IPO on 2014-08-07. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The firm's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. The company also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
Company Info
T2 BIOSYSTEMS INC
101 Hartwell Ave
Lexington MASSACHUSETTS 02421 US
CEO: John Sperzel
Employees: 113
Phone: 17814571200
T2 BIOSYSTEMS INC / TTOO FAQ
What is the stock price of T2 BIOSYSTEMS INC today?
The current stock price of TTOO is 0.134 USD. The price decreased by -31.07% in the last trading session.
What is the ticker symbol for T2 BIOSYSTEMS INC stock?
The exchange symbol of T2 BIOSYSTEMS INC is TTOO and it is listed on the Nasdaq exchange.
On which exchange is TTOO stock listed?
TTOO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for T2 BIOSYSTEMS INC stock?
6 analysts have analysed TTOO and the average price target is 5.1 USD. This implies a price increase of 3705.97% is expected in the next year compared to the current price of 0.134. Check the T2 BIOSYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is T2 BIOSYSTEMS INC worth?
T2 BIOSYSTEMS INC (TTOO) has a market capitalization of 3.76M USD. This makes TTOO a Nano Cap stock.
How many employees does T2 BIOSYSTEMS INC have?
T2 BIOSYSTEMS INC (TTOO) currently has 113 employees.
Is T2 BIOSYSTEMS INC (TTOO) expected to grow?
The Revenue of T2 BIOSYSTEMS INC (TTOO) is expected to grow by 51.43% in the next year. Check the estimates tab for more information on the TTOO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy T2 BIOSYSTEMS INC (TTOO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TTOO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TTOO, evaluating the profitability, health, valuation and growth aspects
- T2 BIOSYSTEMS INC (TTOO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- T2 BIOSYSTEMS INC (TTOO) Sales and EPS estimates to see what analysts future expectations are.
- T2 BIOSYSTEMS INC (TTOO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- T2 BIOSYSTEMS INC (TTOO) Insider and Institutional Ownership to learn about the owners and their transactions.
- T2 BIOSYSTEMS INC (TTOO) Stock Chart to make your own analysis
- T2 BIOSYSTEMS INC (TTOO) Latest news and press-releases to stay up to date.
Does T2 BIOSYSTEMS INC (TTOO) stock pay dividends?
TTOO does not pay a dividend.
When does T2 BIOSYSTEMS INC (TTOO) report earnings?
T2 BIOSYSTEMS INC (TTOO) will report earnings on 2025-05-05.
What is the Price/Earnings (PE) ratio of T2 BIOSYSTEMS INC (TTOO)?
T2 BIOSYSTEMS INC (TTOO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.82).
What is the Short Interest ratio of T2 BIOSYSTEMS INC (TTOO) stock?
The outstanding short interest for T2 BIOSYSTEMS INC (TTOO) is 0.1% of its float. Check the ownership tab for more information on the TTOO short interest.
TTOO Technical Analysis
TTOO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TTOO. TTOO may be in some trouble as it scores bad on both profitability and health.
TTOO Financial Highlights
Over the last trailing twelve months TTOO reported a non-GAAP Earnings per Share(EPS) of -7.82. The EPS increased by 97.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -237.55% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TTOO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to TTOO. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 83.26% and a revenue growth 51.43% for TTOO